J2KBIO Co., Ltd. (KOSDAQ:420570)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,310.00
-140.00 (-1.66%)
At close: Apr 28, 2026

J2KBIO Revenue

In the year 2025, J2KBIO had annual revenue of 32.97B KRW, down -0.49%. J2KBIO had revenue of 8.61B in the quarter ending December 31, 2025, with 27.22% growth.

Revenue
32.97B
Revenue Growth
-0.49%
P/S Ratio
1.49
Revenue / Employee
610.49M
Employees
54
Market Cap
49.06B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202532.97B-162.83M-0.49%
Dec 31, 202433.13B4.66B16.36%
Dec 31, 202328.47B12.44B77.60%
Dec 31, 202216.03B1.81B12.75%
Dec 31, 202114.22B360.95M2.60%
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ADBiotech 12.90B
Parataxis Korea 9.00M
Poongjeon Pharmacy CO.,LTD. 1.54B
EyeGene 3.57B
MOA Life Plus 11.22B
Kainos Medicine 1.17B
Eutilex.Co.,Ltd 10.29B
HLB Pep 4.96B
Revenue Rankings